(Q40452043)

20 September 2017

title

Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. (English)

1 reference

20 September 2017

1 reference

Elisabetta Tabolacci

1

1 reference

20 September 2017

Roberta Pietrobono

2

1 reference

20 September 2017

Umberto Moscato

3

1 reference

20 September 2017

Ben A Oostra

4

1 reference

20 September 2017

Pietro Chiurazzi

5

1 reference

20 September 2017

Giovanni Neri

6

1 reference

20 September 2017

publication date

1 May 2005

1 reference

European Journal of Human Genetics

20 September 2017

published in

1 reference

20 September 2017

volume

13

1 reference

20 September 2017

issue

5

1 reference

20 September 2017

page(s)

641-648

1 reference

Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Translational suppression by trinucleotide repeat expansion at FMR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Absence of expression of the FMR-1 gene in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

High functioning fragile X males: demonstration of an unmethylated fully expanded FMR-1 mutation associated with protein expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Normal phenotype in two brothers with a full FMR1 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

In vitro reactivation of the FMR1 gene involved in fragile X syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

CpG methylation, chromatin structure and gene silencing-a three-way connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Acetylated histones are associated with FMR1 in normal but not fragile X-syndrome cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Cellular memory and the histone code

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Heterochromatin and epigenetic control of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

An epigenetic road map for histone lysine methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Histone modifications depict an aberrantly heterochromatinized FMR1 gene in fragile x syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Elevated levels of FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Correlation between histone lysine methylation and developmental changes at the chicken beta-globin locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Modulation of methylation in the FMR1 promoter region after long term treatment with L-carnitine and acetyl-L-carnitine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Maintenance of stable heterochromatin domains by dynamic HP1 binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Histone methylation in transcriptional control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Molecular dissection of the events leading to inactivation of the FMR1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

Butyrate and acetyl-carnitine inhibit the cytogenetic expression of the fragile X in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EJHG.5201393

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.EJHG.5201393

1 reference

Dimensions Publication ID

20 September 2017

1004367973

0 references

1 reference